Literature DB >> 9278467

Low-molecular-weight heparins.

J I Weitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9278467     DOI： 10.1056/NEJM199709043371007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  184 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

2.  Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

Authors:  R S McLeod; W H Geerts; K W Sniderman; C Greenwood; R C Gregoire; B M Taylor; R E Silverman; K G Atkinson; M Burnstein; J C Marshall; C J Burul; D R Anderson; T Ross; S R Wilson; P Barton
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 3.  Regular review: treatment possibilities for unstable angina.

Authors:  A Manhapra; S Borzak
Journal:  BMJ       Date:  2000-11-18

Review 4.  Update in internal medicine.

Authors:  F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal:  Arch Med Res       Date:  2000 Jul-Aug       Impact factor: 2.235

5.  Fusion of two distinct peptide exosite inhibitors of Factor VIIa.

Authors:  Martin Roberge; Mark Peek; Daniel Kirchhofer; Mark S Dennis; Robert A Lazarus
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

6.  New advances in the management of acute coronary syndromes.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

Review 7.  New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.

Authors:  Walter Ageno; Alexander G G Turpie
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

8.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

9.  Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.

Authors:  Nicola Volpi; Francesca Maccari; Robert J Linhardt
Journal:  Anal Biochem       Date:  2009-02-14       Impact factor: 3.365

10.  Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.

Authors:  Jason P Sulkowski; Thomas J Preston; Jennifer N Cooper; Victoria L Duffy; Katherine J Deans; Louis G Chicoine; Peter C Minneci
Journal:  J Extra Corpor Technol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.